Be part of the knowledge.™

NeuroFrontiers

Clinical research and advancements furthering clinicians’ ability to diagnose and treat neurological disorders never stop. And neither does NeuroFrontiers, a series dedicated to covering them all. Here neurology specialists will find essential updates on conditions affecting the nervous system, spinal cord, and overall brain health.

So if you want to stay up to date on the latest clinical research and news on neurological disorders, then look no further. Because NeuroFrontiers is where neurology specialists and great minds explore the mind itself.

260

LikeLikedUnlike

256-270 of 347

Clarity for Schizophrenia: The Latest in Drug Treatment
Psych Congress Action Center
Clarity for Schizophrenia: The Latest in Drug Treatment
New Drug Approved for PPD: Solving an Unmet Need
NeuroFrontiers
New Drug Approved for PPD: Solving an Unmet Need
Studying the Safety of Discontinuing DMTs in MS Older Adults
NeuroFrontiers
Studying the Safety of Discontinuing DMTs in MS Older Adults
- Andrew Wilner, MD, FACP, FAAN
  Peer
- John R. Corboy, MD
  Peer
Uncovering Disease Progression in Multiple Sclerosis
NeuroFrontiers
Uncovering Disease Progression in Multiple Sclerosis
- Sergio Baranzini, PhD
  Peer
Examining the Correlation Between HIV & Neurocognitive Disorders
NeuroFrontiers
Examining the Correlation Between HIV & Neurocognitive Disorders
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Santosh Kumar, PhD
  Peer
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
NeuroFrontiers
Prescribing Controlled Substances Through Telehealth: Post-Pandemic Considerations
- Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA
  Peer
- Ashley Baker, MSN, PMHNP
  Peer
advertisement
NIH Study Identifies Cause for Long COVID Neurological Symptoms
NeuroFrontiers
NIH Study Identifies Cause for Long COVID Neurological Symptoms
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Avindra Nath, MD
  Peer
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
NeuroFrontiers
Diagnosing & Treating Neurocognitive Disorders in the Psychiatric Setting
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Lokesh Shahani, MD, PhD, MPH, FACP, FASAM
  Peer
Combating Controversies in BPSD Care
NeuroFrontiers
Combating Controversies in BPSD Care
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
  Peer
Music Therapy Improves Schizophrenia Symptoms in the Inpatient Setting
NeuroFrontiers
Music Therapy Improves Schizophrenia Symptoms in the Inpatient Setting
The Cell Death Pathway: Leveraging Glioblastoma Treatments
NeuroFrontiers
The Cell Death Pathway: Leveraging Glioblastoma Treatments
- Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"
  Peer
- Dominique Higgins, MD, PhD
  Peer
Stopping Stigma Surrounding Monkeypox with Provider Education
NeuroFrontiers
Stopping Stigma Surrounding Monkeypox with Provider Education
advertisement
What Patients with Psychiatric Disorders Expect & Prefer for Medication & SMD
NeuroFrontiers
What Patients with Psychiatric Disorders Expect & Prefer for Medication & SMD
What to Expect at the 2023 APA Annual Meeting
NeuroFrontiers
What to Expect at the 2023 APA Annual Meeting
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
  Peer
Treating BPSD with Cannabinoids: What We Currently Know
NeuroFrontiers
Treating BPSD with Cannabinoids: What We Currently Know
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Rajesh Rajagopalan Tampi, MBBS, MS, DFAPA
  Peer

Program Chapters

Segment Chapters

Playlist:

Recommended